Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Sanofi-aventis 1Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Sanofi-aventis 1Q

Pharmaceutical sales were $8.6 billion (-1%). Lovenox sales were $1.0 billion (+1%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi-aventis 1Q

1Q Revenues: $9.4 billion (+3%)

1Q Earnings: $2.9 billion (flat)

Comments: Pharmaceutical sales were $8.6 billion (-1%). Lovenox sales were $1.0 billion (+1%). Lantus sales were $993.0 million (+27%). Plavix sales were $910.6 million (+4%). Taxotere sales were $709.8 million (+8%). Eloxatin sales were $457.3 million (-7%) with European sales impacted by generic competition. Aprovel sales were up 11% to $417.4 million. Apidra sales were up 43% to $41.2 million. Vaccine sales were up 9% to $833.5 million. Earnings were up 16% in local currencies.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters